Black patients with multiple myeloma have better survival than white patients when treated equally: a matched cohort study.

For patients diagnosed in 2008 and later, by when 75% of newly diagnosed patients in the US received one of the new agents as part of their initial therapy, the racial survival difference was marginally significant in the treatment match, indicating that the widespread use of novel agents helped to reduce the racial survival disparity (Supplementary Table 4 ).

also in 26,082 other papers